LAURUS LABS
Back to Balance Sheet
|
LAURUS LABS Last 5 Year Deferred Tax Assets / Liabilities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Deferred Tax Assets / Liabilities | ₹29 Cr | ₹32 Cr | ₹57 Cr | ₹82 Cr | ₹69 Cr |
What is the latest Deferred Tax Assets / Liabilities ratio of LAURUS LABS ?
| Year | Deferred Tax Assets / Liabilities |
|---|---|
| Mar2026 | ₹29 Cr |
| Mar2025 | ₹32 Cr |
| Mar2024 | ₹57 Cr |
| Mar2023 | ₹82 Cr |
| Mar2022 | ₹69 Cr |
How is Deferred Tax Assets / Liabilities of LAURUS LABS Trending?
| Years | Deferred Tax Assets / Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | ₹29 Cr | -7.81 | |
| Mar2025 | ₹32 Cr | -44.13 | |
| Mar2024 | ₹57 Cr | -30.82 | |
| Mar2023 | ₹82 Cr | 19.30 | |
| Mar2022 | ₹69 Cr | - | |
Compare Deferred Tax Assets / Liabilities of peers of LAURUS LABS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| LAURUS LABS | ₹107,951.9 Cr | -1.1% | -1% | 129.8% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹420,831.0 Cr | -0.4% | -6.1% | 5.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹242,074.0 Cr | 0.9% | -3.3% | 39.2% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹175,355.0 Cr | 0.1% | -7.2% | 28.2% | Stock Analytics | |
| CIPLA | ₹107,439.0 Cr | -0.3% | -4% | -15.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹103,417.0 Cr | 1.5% | 3.1% | 0.4% | Stock Analytics | |
LAURUS LABS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| LAURUS LABS | -1.1% |
-1% |
129.8% |
| SENSEX | 0.6% |
-1.4% |
-10.7% |
You may also like the below Video Courses